ProfileGDS5822 / ILMN_2812164
TitleAnti-CTLA-4 immunotherapy effect on αSMA+ myofibroblast late-depleted pancreatic ductal adenocarcinoma model
OrganismMus musculus


control myofibroblast depletion untreated anti-CTLA4 antibody GSM1276599 GSM1276600 GSM1276601 GSM1276602 GSM1276603 GSM1276604 GSM1303940 GSM1303941 GSM1303942 76% 79% 79% 75% 79% 73% 82% 78% 75% sort by protocol sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM1276599PDAC Late Ablation Control 185.476
GSM1276600PDAC Late Ablation Control 2142.379
GSM1276601PDAC Late Ablation Control 3168.479
GSM1276602PDAC Late Ablation 182.575
GSM1276603PDAC Late Ablation 2140.279
GSM1276604PDAC Late Ablation 376.973
GSM1303940PDAC Late Ablation_anti-CTLA4 1179.682
GSM1303941PDAC Late Ablation_anti-CTLA4 2153.978
GSM1303942PDAC Late Ablation_anti-CTLA4 311175